Cryoport, Inc. (CYRX)

Market Cap	324.76M
Revenue (ttm)	226.11M
Net Income (ttm)	-166.47M
Shares Out	49.43M
EPS (ttm)	-3.39
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	567,933
Open	6.90
Previous Close	6.94
Day's Range	6.48 - 6.94
52-Week Range	5.32 - 20.11
Beta	1.63
Analysts	Buy
Price Target	13.14 (+100.0%)
Earnings Date	Nov 7, 2024

About CYRX

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controll...

• Industry: Integrated Freight & Logistics
• Sector: Industrials
• Founded: 1999
• Employees: 1,030
• Stock Exchange: NASDAQ
• Ticker Symbol: CYRX
• Website: https://www.cryoportinc.com

Financial Performance

In 2023, Cryoport's revenue was $233.26 million, a decrease of -1.70% compared to the previous year's $237.28 million. Losses were -$107.59 million, 137.3% more than in 2022.

Analyst Forecast

According to 7 analysts, the average rating for CYRX stock is "Buy." The 12-month stock price forecast is $13.14, which is an increase of 100.00% from the latest price.

Price Target

$13.14

(100.00% upside)

Analyst Consensus: Buy